Loading clinical trials...
Loading clinical trials...
A Biomarker Screening Protocol to Support Preliminary Eligibility for Clinical Trials Evaluating Safety and Efficacy of Adoptive T-cell Therapies in Participants With Solid Tumors
Conditions
Locations
1
United States
Accellacare
Rocky Mount, North Carolina, United States
Start Date
May 19, 2023
Primary Completion Date
February 5, 2025
Completion Date
February 5, 2025
Last Updated
July 1, 2025
NCT06043817
NCT05671510
NCT07144280
NCT06758401
NCT03340506
NCT07431827
Lead Sponsor
Lyell Immunopharma, Inc.
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions